Skip to content
TrustList
NC
Venture capital firm

North Carolina Venture Capital Multiplier Fund

State-backed venture capital co-investment fund in North Carolina managed by Hatteras Venture Partners

  • Carolina
  • Management
  • Property
  • Medical
  • +4 more
North Carolina Venture Capital Multiplier Fund cover

About North Carolina Venture Capital Multiplier Fund

A state-backed fund for co-investing in North Carolina

The Venture Capital Multiplier Fund was set up to put capital into young companies with a North Carolina link, working alongside venture firms and angel investors that are already involved. The fund was made public on 28 February 2017, after the State of North Carolina chose Hatteras Venture Partners to manage it. The fund sits within the relationship Hatteras already had with the state's Treasurer.

How the capital is used

Most of the fund's money is meant for co-investments, though a portion was committed to the latest Hatteras fund, Hatteras Venture Partners V. The idea in its name is multiplication: by investing next to existing institutional private equity managers and professionally run angel networks, the fund aims to stretch early-stage investments that are already under way and bring more capital to high-growth companies in the state.

What counts as a North Carolina nexus company

A company qualifies if it meets any one of four tests:

  • it is headquartered in North Carolina;
  • it has significant operations in the state;
  • it is commercializing intellectual property developed in North Carolina;
  • an investment would lead it to start, expand or restructure significant operations there.

People and partnerships

To run the co-investment program, Hatteras brought in a special advisor who also sits on the fund's investment committee. This advisor, previously a co-founder of a firm that advises on private fund investments, took charge of finding and developing co-investment relationships with other venture firms and early-stage investors. Managers across the state and beyond were already being approached to build structures that would draw on their existing capital and expertise.

The manager behind it

Hatteras Venture Partners is based in Research Triangle Park, North Carolina, and concentrates on seed and early-stage deals in biopharmaceuticals, medical devices, diagnostics, healthcare IT and related parts of human medicine. It manages five venture capital funds and describes a team of entrepreneurs and operators with a record in seed and early-stage investing and company formation. At the time of the announcement it had invested in 22 private companies headquartered in or substantially operating in North Carolina. The General Partner pointed to companies such as Viamet, Clinipace, G1 Therapeutics, Medfusion, NeuroTronik, GeneCentric and Spyryx, and said that Hatteras's own investments had drawn many times their value from co-investors.

TrustList summary

The North Carolina Venture Capital Multiplier Fund is a venture capital vehicle set up with the State of North Carolina and run by Hatteras Venture Partners. Its launch was announced on 28 February 2017. Most of its capital is meant for co-investing alongside other venture funds and angel investors in companies with a North Carolina link.

What the North Carolina Venture Capital Multiplier Fund does

  • Co-investment: putting money into early-stage companies alongside other venture firms and early-stage investors.
  • Fund commitment: a portion of the capital is committed to Hatteras Venture Partners V.
  • Investor partnerships: a special adviser, Charles Merritt, helps build co-investment relationships with other managers.

Customers and markets

The fund targets companies with a North Carolina nexus, meaning they are headquartered in the state, have significant operations there, commercialise intellectual property developed there, or would set up or expand major operations there after an investment.

Key facts

  • Manager: Hatteras Venture Partners, based in Research Triangle Park, North Carolina
  • Manager's focus: seed and early-stage biopharmaceuticals, medical devices, diagnostics and healthcare IT
  • Manager's record: investments in 22 private companies with North Carolina roots
  • Announced: February 2017

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Carolina
  • Management
  • Property
  • Medical
  • Us,
  • North Carolina
  • Partners
  • Venture Capital

Ask TrustList to introduce you to North Carolina Venture Capital Multiplier Fund

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of North Carolina Venture Capital Multiplier Fund

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about North Carolina Venture Capital Multiplier Fund.

North Carolina Venture Capital Multiplier Fund alternatives

Similar listings buyers compare against this one.

Private equity and advisory firm working hands-on with mid-sized companies in distribution, healthcare and industrial sectors

Energy-focused investment firm with private equity, credit, venture and shared services businesses

Life sciences venture investment firm funding pharmaceutical and medical device startups

Healthcare venture growth investor in biotechnology, medical technology and health solutions companies

Early-stage healthcare and life sciences investor providing capital, advice and team-building support

Athens venture capital manager investing in growing small and medium enterprises in Greece

Investment bank advising digital media and marketing companies on mergers, acquisitions and strategic deals